by Dr. Agresti | Jan 21, 2022 | Blog
This week, I could write a blog on the psychosocial ramifications of long term isolation, or the effects of fear of contracting coronavirus on people with anxiety disorder, or tips on how to ride this pandemic out. I could do any and all of that, but to be honest, I’m...
by Dr. Agresti | Jan 21, 2022 | Blog
Caplyta (lumateperone): New for Schizophrenia…and More? Before we talk about Caplyta (lumateperone), I want to announce that I take no remuneration of any kind from any pharmaceutical or healthcare company. I am providing the following information solely for...
by Dr. Agresti | Jan 21, 2022 | Blog
The Skinny on Psychostimulants, Part 3: Modafinil Over the past two weeks, we’ve been discussing the psychostimulants amphetamines and methylphenidate, which stimulate the central nervous system by increasing synaptic concentrations of the neurotransmitters dopamine...
by Dr. Agresti | Jan 21, 2022 | Blog
The Skinny on Psychostimulants, Part 3: Modafinil Over the past two weeks, we’ve been discussing the psychostimulants amphetamines and methylphenidate, which stimulate the central nervous system by increasing synaptic concentrations of the neurotransmitters dopamine...
by Dr. Agresti | Jan 21, 2022 | Blog
Dark Side of OCD Hello, people! Thanks for checking out the blog. Last week, I introduced a new series on unusual OCD subtypes, the darker side of OCD, with compulsions that go beyond the stereotypical examples most people think of. While doubt is still the core...
by Dr. Agresti | Jan 21, 2022 | Blog
OBSESSIVE COMPULSIVE DISORDER (Darker Subtypes) Hello, people! Welcome back to the blog, where we’re continuing our discussion of some darker OCD subtypes. Last week we talked about emotional contamination OCD, which is when people become obsessed with the idea that...
